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Abstract Three transmembrane glutamic acid residues play 
essential roles in the metal-tetracycline/H+ antiporter Tet(K) of 
Staphylococcus aureus [Fujihira et al., FEBS Lett. 391 (1996) 
243-246]. In the putative hydrophilic loop region of the Tet(K) 
and Tet(L) proteins, six acidic residues are conserved. Asp74, 
Asp200, Asp318 and Glu381 are located on the putative 
cytoplasmic side, and Asp39 and Glu345 on the putative 
periplasmic side. These residues were replaced by a neutral 
amino acid residue or a charge-conserved one. In contrast to the 
transmembrane glutamic acid residues, the replacement of the 
two glutamic acid residues (Glu345 and Glu381) did not affect the 
tetracycline resistance level. Out of the other four aspartic acid 
residues, the only essential residue is Asp318, any replacement of 
which resulted in complete loss of the tetracycline resistance and 
transport activity. Asp318 is located in cytoplasmic loop 10-11 in 
the putative 14-transmembrane-segment topology of Tet(K). In 
the case of the tetracycline exporters of Gram-negative bacteria, 
the only essential acidic residue in the cytoplasmic loop region is 
located in loop 2-3 [Yamaguchi et al., Biochemistry 31 (1992) 
8344-8348). It may be a general role for tetracycline efflux 
proteins that three transmembrane and one cytoplasmic acidic 
residues are mandatory for the tetracycline transport function. 
© 1997 Federation of European Biochemical Societies. 
Key words: Tetracycline resistance; Site-directed 
mutagenesis; Acidic residue; Efflux protein; Antibiotic 
resistance 
1. Introduction 
Most of the tetracycline-resistant determinants of enteric 
bacteria are based on the drug efflux mechanism, whereas 
the resistance determinants of Gram-positive bacteria are 
based on the ribosomal protection mechanism [1,2] as well 
as the drug efflux mechanism [3,4]. Tetracycline exporters of 
Gram-positive bacteria are classified into Tet(K), from Sta-
phylococcus aureus [5], and Tet(L), from Bacillus subtilis [6], 
whose amino acid sequences show about 65% similarity [7]. 
The tetracycline exporter genes of Gram-positive bacteria are 
phylogenetically distant from those of enteric tetracycline ex-
porters such as Tet(B) and Tet(C) [8]. Their molecular sizes 
are about 50 kDa, which is larger than the 43 kDa of the 
enteric tetracycline exporters. Hydropathic analysis of 
Tet(K) and Tet(L) revealed that their membrane topologies 
contain 14 membrane-spanning segments [8], whereas Tet(B) 
and Tet(C) were found to have a 12 membrane-spanning 
structure, like major facilitator family transporters [9]. 
Although there are large differences in their molecular sizes 
and membrane topologies, Tet(K) mediates active tetracycline 
*Corresponding author. 
efflux on the basis of the same molecular mechanism as in the 
case of Tet(B) [10], that is, it exports a monocationic metal-
tetracycline complex through antiport with a proton [11]. The 
antiport seems to be electrically neutral [12], similar to that in 
the case of Tet(B) [13], while Tet(L) of B. subtilis has been 
reported to mediate the electrical exchange of metal-tetracy-
cline and protons [14]. 
There are three transmembrane aspartic acid residues con-
served in the enteric tetracycline exporters which are essential 
for the tetracycline transport function [15]. On the other hand, 
Tet(K) and Tet(L) do not contain any aspartic acids in their 
putative transmembrane regions, while three glutamic acids 
are conserved [16,17]. We found that these transmembrane 
glutamic acid residues play similar roles to the transmembrane 
aspartic acid residues of Tet(B) and Tet(C) in site-directed 
mutagenesis [17]. In particular, Glu397 in transmembrane helix 
XIII, which is the only transmembrane acidic residue in the C-
terminal half of Tet(K), showed very similar behavior on mu-
tation to Asp28° in helix IX of Tet(B), which is also the only 
acidic residue in the C-terminal half of Tet(B) [15]. On the 
basis of the symmetrical distribution of essential acidic resi-
dues in the N- and C-terminal halves, we proposed a 12 mem-
brane-spanning structure for Tet(K) in our previous paper 
[17]. However, a 14 membrane-spanning structure of Tet(K) 
has been experimentally indicated by PhoA fusion experi-
ments [18]. 
In this article, we report the roles of acidic residues located 
in the hydrophilic loop regions of Tet(K). Tet(K) and Tet(L) 
contain greatly modified forms of the conserved sequence mo-
tifs of major facilitator family transporters like Tet(B) and 
Tet(C). The first motif, GKXSDRXGRR, in loop 2-3 of 
Tet(B), is modified to GKXSDXXXXKK in loop 2-3 of 
Tet(K), and the second motif, GRXXXKXGEK, in Tet(B) 
is modified to GXXXDRKG in loop 10-11 in Tet(K). Two 
(Asp74 and Asp318) of the six conserved acidic residues in the 
hydrophilic region are located in these conserved motifs. Out 
of the other four residues, two (Asp200 and Glu381) are on the 
cytoplasmic side and two (Asp39 and Glu345) on the periplas-
mic side. In this study, Tet(K) and the mutant genes were 
constitutively expressed in Escherichia coli, and the tetracy-
cline transport in everted membrane vesicles prepared from 
E. coli cells was measured. 
2. Materials and methods 
2.1. Materials 
[7-3H(yV)]Tetracycline was purchased from DuPont-New England 
Nuclear. All other chemicals were of reagent grade and were obtained 
from commercial sources. 
2.2. Bacterial strains and plasmids 
E. coli W3104 [19] was used as the host strain for expression of the 
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tet(K.) gene and for the preparation of everted membrane vesicles. 
pTZ1252, which was a gift from N. Noguchi, Tokyo College of Phar-
macy, was constructed by insertion of a 2.3 kbp Hindlll fragment of 
pNSl, which carries the tet(íQ gene of S. aureus [4], into pUC119, in 
which the initiation codon and the ribosome binding sequence (RBS) 
were changed from TTG to ATG and from GAGG to GGAGG, 
respectively, and the distance between the RBS and the initiation 
codon was altered from 4 to 11 bases [20]. pTKNl and pTKC3 are 
plasmids constructed by subcloning of the 5'- and 3'-halves of the 
tet(K) gene, respectively, into pUC118 [21] and pUC119, respectively. 
pTKNl was constructed by insertion of the EcoRl-Kpnl fragment of 
pTZ1252 into the corresponding cloning site of pUC118. pTKC3 was 
constructed by insertion of the Hindlll-Kpnl fragment of pTZ1252 
into the corresponding cloning site of pUC119. 
2.3. Site-directed mutagenesis 
Mutagenesis at codons 39 and 74, and at codons 200, 318, 345 and 
381 in the tet(K.) gene was performed using pTKNl and pTKC3, 
respectively, as templates. The method employed for mutagenesis 
was mainly that of Kunkel [22]. The mutagenic primers used are listed 
in Table 1. A mutation was first detected by restriction analysis and 
then confirmed by DNA sequencing. The mutant tet(K) gene was 
reconstructed from mutant pTKNl or pTKC3 by corresponding frag-
ment exchange with pTZ1252. 
2.4. Preparation of inverted membrane vesicles and transport assaying 
Everted membrane vesicles were prepared from E. coli W3104 cells 
harboring pTZ1252 or a mutant plasmid, as described in our previous 
paper [11]. Respiration-driven [3H]tetracycline uptake by everted 
membrane vesicles was measured in the presence of 10 iiM 
[3H]tetracycline and 50 U.M C0CI2, as described previously [11]. 
3. Results and discussion 
3.1. Distribution of conserved acidic residues in the putative 
hydrophilic region of Tet(K) 
The 14 hydrophobic segments, whose length was enough to 
traverse the membrane once, were estimated by hydropathy 
analysis of the Tet(K) protein [8]. In our previous paper, the 
two central hydrophobic segments were postulated to be in 
the large cytoplasmic loop because of the theoretical symme-
try of the distribution of essential transmembrane acidic res-
idues in the N- and C-terminal halves of Tet(K) [17]. How-
ever, after that, since we obtained experimental evidence that 
the region between central helices VII and VIII is located on 
the periplasmic side in PhoA fusion experiments (unpublished 
observation), the 14 membrane-spanning structure seems to be 
Table 1 
Mutagenic primers used for site-directed mutagenesis 
primer nucleotide sequence 
codon amino acid 
change substitution 
5' -TCTTTACCTAATATTGC AAATC-3' GAT^AAT Asp^Asn 
Sspl 
5'-TGGAAAGCTTTCTAATTATA-3' GAT^AAT Asp^Asn 
Hinan 
D74E 
D200N 
5'-ATGGAAAGCTTTCTGAGTATATA-3' GAT^GAG Asp^Glu 
HindU 
5' - ATAC ATTAAATATTGTAGGTAT-3' GAT^AAT Asp^Asn 
Sspl 
D318N 5'-GGI I I I I IAGTTAACAGAAAAGG-3' GAT^AAC Asp-»Asn 
Hpal 
D318E 5'-AGTGGAGAGAAAAGGGTCCTTAT-3' GAT^GAG Asp->Glu 
AvaW 
E345Q 5'-TTGTTCAGTTTAGrjAIGTGGTTG-3' GAG^CAG Glu—Gin 
Nspl 
E381Q 5'-AAGAACAAGTTGCTAGCGGAATG-3' GAA-»CAA Glu^GIn 
Nhe\ 
Asterisks indicate mismatched bases which generate an amino acid 
replacement and a new restriction site. The underlined letters indi-
cate the new restriction site. 
correct. Ginn et al. also proposed a 14 membrane-spanning 
structure on the basis of the results of a PhoA fusion experi-
ment [18], as well as QacA/B [23]. Our proposed structure 
(Fig. 1) is almost the same as that proposed by Ginn et al. 
[18], except for a minor discrepancy as to the boundary be-
tween the loop and membrane-embedded regions. Out of nine 
conserved acidic residues, six including Asp200 are located in 
the hydrophilic region in our topology, while Asp200 is located 
in the N-terminal region of transmembrane helix VII in the 
topology of Ginn et al. [18]. 
3.2. Effect of replacement of conserved acidic residues in the 
hydrophilic region of Tet(K) 
Table 2 shows the tetracycline resistance level of E. coli 
W3104 cells harboring plasmid pTZ1252 or its derivative en-
coding a mutant tet(K) gene. When the two glutamic acids, 
cytoplasm 
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Fig. 1. Putative 14 membrane-spanning structure of the Tet(K) protein on the basis of hydropathy analysis. Conserved acidic residues in the 
hydrophilic loop and transmembrane regions are indicated by bold and outlined letters, respectively. 
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Fig. 2. Tetracycline uptake by everted membrane vesicles prepared 
from E. coli W3104 cells harboring pTZ1252 or its derivatives en-
coding mutant Tet(K) proteins whose conserved acidic residue was 
replaced by a neutral amino acid. Closed and open symbols indicate 
the uptake by vesicles in the presence and absence of NADH, re-
spectively, as an energy source. 
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Fig. 3. Tetracycline uptake by everted membrane vesicles prepared 
from E. coli W3104 cells harboring a plasmid encoding a mutant 
Tet(K) protein whose Asp74 or Asp318 is replaced by a glutamic 
acid residue. Open and closed symbols indicate the uptake in the 
presence and absence of an energy source, respectively. 
mic acid replacement were significantly higher than those of 
ones with asparagine replacement (Table 2). 
Tetracycline transport activity was measured in everted 
membrane vesicles containing these mutant Tet(K)s (Figs. 2 
and 3), as described in Section 2. As expected, the two gluta-
mic acid replacement mutants (E345Q and E381Q) showed 
high transport activity, i.e. about 35-60% of the wild-type 
level. With respect to the three aspartic acid mutants, 
D39N, D74N and D200N, the first (D39N) showed the high-
est residual activity, while its resistance level was the lowest of 
these three mutants. The D74N mutant showed very low ac-
tivity, i.e. about 5% of the wild-type level. Only the D318N 
mutant completely lost its transport activity. As to the charge-
conserved mutants, the D318E mutant showed no transport 
activity, while the D74E mutant retained high activity, i.e. 
about 35% of the wild-type level. 
On the basis of these results, it can be concluded that the 
only essential residue in the hydrophilic region of Tet(K) is 
Asp318. As judged from the resistance level, a negative charge 
at this position plays an essential role in the transport func-
tion. Asp318 is located in the putative cytoplasmic loop be-
tween helices X and XI of the C-terminal half of Tet(K) (Fig. 
1). It is the only negatively charged residue in the second 
conserved motif. In contrast, Asp74, which is the only nega-
tively charged residue in the first conserved motif, plays some 
role in the transport process but is not mandatory. In the case 
of Tet(B), there is no acidic residue at the corresponding po-
sition of the second motif [24]. Only the acidic residue in the 
second motif, Glu274, of Tet(B) is not essential [24]. The only 
essential acidic residue in the hydrophilic region of Tet(B) is 
Asp66 in the first motif [25], which corresponds to Asp74. It is 
not yet obvious why the position of the essential acidic residue 
Glu345 and Glu381, were replaced by glutamine, the resulting 
mutants conferred the same level of tetracycline resistance as 
the wild type (Table 2). On the other hand, when four con-
served aspartic acid residues were replaced by asparagine, the 
level of resistance was more or less reduced. These results 
indicated that, in contrast to in the transmembrane region, 
aspartic acid residues play a more important role in the hy-
drophilic region of Tet(K) than glutamic acid residues. The 
replacement of Asp39, Asp74 and Asp200 with neutral residues 
resulted in a moderate level of resistance (Table 2). Only the 
replacement of Asp318 with a neutral residue caused complete 
loss of the resistance. With respect to Asp74 and Asp318, these 
residues were each replaced with a charge-conserved glutamic 
acid residue. The resistance levels of the mutants with gluta-
Table 2 
Tetracycline resistance (shown as the minimum inhibitory concentra-
tion (MIC)) of E. coli W3104 cells harboring plasmids encoding mu-
tant Tet(K) proteins 
Mutant 
No plasmid 
pTZ1252 
D39N 
D74N 
D200N 
D318N 
E345Q 
E381Q 
D74E 
D318E 
MIC (ug/ml) 
0.8 
25 
4.7 
9.5 
9.5 
0.8 
25 
25 
12.5 
4.7 
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is in the C-terminal half in Tet(K), al though the most essential 
t ransmembrane acidic residue, Glu3 9 7 , is in the C-terminal 
half of Tet(K), similar to Asp2 8 5 in Tet(B). It may be a general 
rule for tetracycline transporters that three t ransmembrane 
residues and one cytoplasmic acidic residue are mandatory 
for the tetracycline t ransport function. 
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